UBS (Lux) Equity Fund: Other legal notices (concern also modifications of regulations and prospectuses) as of 23.09.2024

Fund Name  NAV  Issue Price  Redemption Price  Closing Price  Trading Information SIX YTD Perf.  MyFunds
UBS (Lux) Equity Fund - Biotech (USD) (EUR) Q-acc
LU1769088235
100.32 EUR
17.12.2024
100.32 EUR
17.12.2024
100.32 EUR
17.12.2024
+1.50%
UBS (Lux) Equity Fund - Biotech (USD) (SEK) P-acc
LU1991432631
957.28 SEK
17.12.2024
957.28 SEK
17.12.2024
957.28 SEK
17.12.2024
+3.70%
UBS (Lux) Equity Fund - Biotech (USD) P-acc
LU0069152568
S
685.02 USD
17.12.2024
685.02 USD
17.12.2024
685.02 USD
17.12.2024
-4.48%
UBS (Lux) Equity Fund - Biotech (USD) Q-acc
LU0400035332
305.31 USD
17.12.2024
305.31 USD
17.12.2024
305.31 USD
17.12.2024
-3.53%
UBS (Lux) Equity Fund - Biotech (USD) QL-acc
LU2208649280
99.37 USD
17.12.2024
99.37 USD
17.12.2024
99.37 USD
17.12.2024
-3.35%
UBS (Lux) Equity Fund - China Opportunity (USD) (AUD hedged) P-acc
LU1227825731
96.48 AUD
18.12.2024
96.48 AUD
18.12.2024
96.48 AUD
18.12.2024
+3.56%
UBS (Lux) Equity Fund - China Opportunity (USD) (AUD hedged) P-mdist
LU1230129766
78.98 AUD
18.12.2024
78.98 AUD
18.12.2024
78.98 AUD
18.12.2024
+3.56%
UBS (Lux) Equity Fund - China Opportunity (USD) (EUR hedged) P-acc
LU2000522420
S
71.43 EUR
18.12.2024
71.43 EUR
18.12.2024
71.43 EUR
18.12.2024
+3.37%
UBS (Lux) Equity Fund - China Opportunity (USD) (EUR hedged) Q-acc
LU2191389209
57.28 EUR
18.12.2024
57.28 EUR
18.12.2024
57.28 EUR
18.12.2024
+4.32%
UBS (Lux) Equity Fund - China Opportunity (USD) (EUR) I-A1-acc
LU2084644850
Q
79.83 EUR
18.12.2024
79.83 EUR
18.12.2024
79.83 EUR
18.12.2024
+11.79%
/ Add to MyFunds list / Delete from MyFunds list
/ Add to comparison list / Remove from comparison list
Q
Fund for qualified investors
E
The fund is an ETF / The fund is an ETSF
S
The fund is a Sponsored Fund
* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price